NCT03650803View on ClinicalTrials.gov

Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Breast Cancer
Interventions
DEVICE

3D MR Fingerprinting scan

"3D MR Fingerprinting technique is a non-contrast technique and generates quantitative information about MR-visible tumors without having to administer contrast.~MR Fingerprinting software is used in conjunction with a standard-of-care MRI scan."

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER

NCT03650803 - Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer | Biotech Hunter | Biotech Hunter